Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial
- 20 June 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 65 (5), 1471-1478
- https://doi.org/10.1016/j.ijrobp.2006.02.054
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative ChemoradiationThe Oncologist, 2002
- Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreasJournal of Gastrointestinal Surgery, 2001
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- Combined modality therapy for stage II and stage III pancreatic carcinoma.Journal of Clinical Oncology, 1997
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological studyBritish Journal of Surgery, 1995
- Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancerCancer, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958